样式: 排序: IF: - GO 导出 标记为已读
-
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2 Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-03-17 Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, Taku Yamashita, Koji Araki, Kohei Horimoto, Satoshi Yajima, Masakazu Yashiro, Keigo Yokoi, Haruhiko Cho, Takuya Ehira, Kazunari Nakahara, Hiroshi Yasuda, Kazutoshi Isobe, Tetsu Hayashida, Shingo Hatakeyama, Koichiro Akakura, Daisuke Aoki, Hiroyuki Nomura, Yuji Tada, Yuki Yoshimatsu, Hayato Miyachi, Chiaki Takebayashi, Ichiro Hanamura, Hiroyuki
In recent years, rapid advancement in gene/protein analysis technology has resulted in target molecule identification that may be useful in cancer treatment. Therefore, “Clinical Practice Guidelines for Molecular Tumor Marker, Second Edition” was published in Japan in September 2021. These guidelines were established to align the clinical usefulness of external diagnostic products with the evaluation
-
Salivary gland-type cancers: cross-organ demographics of a rare cancer Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-03-16 Aika Tanzawa, Kengo Saito, Masayuki Ota, Koji Takahashi, Izumi Ohno, Toyoyuki Hanazawa, Katsuhiro Uzawa, Yuichi Takiguchi
-
An approach for improvement of the accuracy of cancer gene panel testing Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-03-12 Kiyomi Imoto, Hiroyuki Yamamoto, Chie Ohkawa, Naoki Shimada, Ryo Ikuzawa, Hiroyuki Takeda, Tatsuru Ohhara, Yasuyuki Kojima, Naoki Furuya, Ai Motoyoshi, Ohsuke Migita, Asami Kuga, Takayuki Keira, Hirotake Wakamatsu, Tomoo Sato, Nobuyuki Oike, Junki Koike, Yoshihisa Yamano, Yu Sunakawa
-
Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysis Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-03-02 Mashio Nakamura, Masato Sakon, Mitsuru Sasako, Takuji Okusaka, Hirofumi Mukai, Keiichi Fujiwara, Hideo Kunitoh, Mari S. Oba, Hideo Wada, Jun Hosokawa, Atsushi Takita, Masataka Ikeda
-
Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-03-02 Masaki Hashimoto, Wataru Fukuokaya, Takafumi Yanagisawa, Shutaro Yamamoto, Yuhei Koike, Yu Imai, Kosuke Iwatani, Hajime Onuma, Kagenori Ito, Fumihiko Urabe, Shunsuke Tsuzuki, Shoji Kimura, Yu Oyama, HIrokazu Abe, Jun Miki, Takahiro Kimura
-
Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-28
Abstract Background Enfortumab vedotin is a novel antibody–drug conjugate used as a third-line therapy for the treatment of urothelial cancer. We aimed to elucidate the effect of enfortumab vedotin-related peripheral neuropathy on its efficacy and whether enfortumab vedotin-induced early electrophysiological changes could be associated with peripheral neuropathy onset. Methods Our prospective multicenter
-
Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with HER2-enriched breast cancer Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-27
Abstract Background Thrombospondin-1 (THBS1) is a secretory adhesive glycoprotein involved in the progression of multiple malignancies, including breast cancer. However, the clinical significance and prognostic role of plasma THBS1 in breast cancer have yet to be clarified. Methods Plasma THBS1 levels in 627 breast cancer patients were analyzed by enzyme-linked immunosorbent assay. Bone marrow blood
-
Current status of head and neck sarcomas in Japan in 2016–2019: an analysis using the national cancer registry Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-27 Ryoko Rikitake, Yu Mizushima, Seiichi Yoshimoto, Takahiro Higashi, Tomoyuki Satake, Chigusa Morizane, Akira Kawai
-
Financial toxicity and patient experience associated with financial burden of molecular-targeted and immune therapies for cancer: an observational study under public health insurance Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-24
Abstract Background Financial burden of cancer treatment can negatively affect patients and their families. This study aimed to evaluate the financial toxicity of patients treated with molecular-targeted and immune therapies and explore the relationship between financial toxicity and patient experiences associated with the financial burden of cancer treatment. Methods This anonymous, self-administered
-
Abnormal activation of RFC3, A YAP1/TEAD downstream target, promotes gastric cancer progression Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-21
Abstract Background Gastric cancer (GC) is a malignant tumor with a high mortality rate, and thus, it is necessary to explore molecular mechanisms underlying its progression. While replication factor C subunit 3 (RFC3) has been demonstrated to function as an oncogene in many cancers, its role in GC remains unclear. Methods Tumor tissues were collected from clinical GC patients, and the expression of
-
Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-21 Yuki Katsuya, Tatsuya Yoshida, Atsuo Takashima, Kan Yonemori, Akihiro Ohba, Shu Yazaki, Shigehiro Yagishita, Hiroko Nakahama, Osamu Kobayashi, Masatoshi Yanagida, Yasuhiro Irino, Akinobu Hamada, Noboru Yamamoto
-
Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021 Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-21 Hidekatsu Nakai, Takahiro Higashi, Tamaki Kakuwa, Noriomi Matsumura
-
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022 Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-14
Abstract Background Granulocyte colony-stimulating factor (G-CSF) is commonly administered to cancer patients undergoing myelosuppressive chemotherapy, especially when incidence rate of febrile neutropenia (FN) surpasses 20%. While primary prophylaxis with G-CSF has been proven effective in preventing FN in patients with cancer, there is limited evidence regarding its efficacy in specifically, lung
-
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-14 Junji Furuse, Fumihiko Osugi, Koji Machii, Koji Niibe, Toshimitsu Endo
-
Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-14 Shigeki Kataoka, Yoshitaka Nishikawa, Taro Funakoshi, Takahiro Horimatsu, Minoru Sakuragi, Eiichiro Uchino, Shusuke Hiragi, Shinya Yamamoto, Kaoru Sakai, Takeshi Matsubara, Motoko Yanagita, Manabu Muto
-
First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-12 Hiroki Ishihara, Kenji Omae, Yuki Nemoto, Ryo Ishiyama, Hidekazu Tachibana, Koichi Nishimura, Takashi Ikeda, Yuki Kobari, Hironori Fukuda, Kazuhiko Yoshida, Hiroaki Shimmura, Yasunobu Hashimoto, Junpei Iizuka, Tsunenori Kondo, Toshio Takagi
-
Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-09 Honami Sato, Takahiro Kobayashi, Yoshihiro Kameoka, Kazuaki Teshima, Atsushi Watanabe, Masahiro Yamada, Takaya Yamashita, Shinsuke Noguchi, Yoshihiro Michisita, Naohito Fujishima, Jun Kuroki, Naoto Takahashi
-
Hydronephrosis severity as a predictor of postoperative renal function decline following laparoscopic radical nephroureterectomy Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-06 Toru Kanno, Go Kobori, Ryoichi Saito, Katsuhiro Ito, Hiromichi Nakagawa, Toshifumi Takahashi, Shigeki Koterazawa, Naoto Takaoka, Shinya Somiya, Takao Haitani, Kanji Nagahama, Masaaki Ito, Yoshihito Higashi, Seiji Moroi, Toshiya Akao, Hitoshi Yamada
-
Skeletal muscle status and survival among patients with advanced biliary tract cancer Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-06 Shinya Takaoka, Tsuyoshi Hamada, Naminatsu Takahara, Kei Saito, Go Endo, Ryunosuke Hakuta, Kota Ishida, Kazunaga Ishigaki, Sachiko Kanai, Kohei Kurihara, Hiroki Oyama, Tomotaka Saito, Tatsuya Sato, Tatsunori Suzuki, Yukari Suzuki, Shuichi Tange, Yurie Tokito, Ryosuke Tateishi, Yousuke Nakai, Mitsuhiro Fujishiro
-
EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-06
Abstract Introduction The developments of perioperative treatments for patients with high-risk early-stage lung cancer are ongoing, however, real-world data and evidence of clinical significance of genetic aberration are lacking in this population. This study aimed to identify patients with early-stage lung adenocarcinoma at high risk for recurrence based on pathological indicators of poor prognosis
-
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-02-04 Hasan Çağrı Yıldırım, Yasin Kutlu, Emel Mutlu, Musa Barış Aykan, Mustafa Korkmaz, Selim Yalçın, Teoman Şakalar, Özde Melisa Celayir, Erkan Kayıkçıoğlu, Ferit Aslan, Emre Hafızoğlu, Yunus Emre Altıntaş, Merve Keskinkılıç, Elvin Chalabiyev, Abdussamet Çelebi, Bengü Dursun, Caner Kapar, Miraç Özen, Ömer Acar, Özgecan Dülgar, Engin Kut, Sedat Biter, Fatih Kus, Elvina Almuradova, Atike Pınar Erdoğan, Seray
-
Low skeletal muscle radiodensity is a risk factor for adjuvant chemotherapy discontinuation in colorectal cancer Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-01-29 Keigo Yokoi, Akiko Watanabe, Kazuko Yokota, Keita Kojima, Toshimichi Tanaka, Ken Kojo, Hirohisa Miura, Takahiro Yamanashi, Takeo Sato, Keishi Yamashita, Yusuke Kumamoto, Naoki Hiki, Takeshi Naitoh
-
Adjuvant and neo-adjuvant therapy for non-small cell lung cancer without EGFR mutations or ALK rearrangements Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-01-28 Masaru Takenaka, Koji Kuroda, Fumihiro Tanaka
-
Impact of sarcopenia on recurrent biliary obstruction after EUS-guided biliary drainage in patients with malignant biliary obstruction Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-01-27 Tomoya Emori, Masahiro Itonaga, Reiko Ashida, Takashi Tamura, Yuki Kawaji, Keiichi Hatamaru, Yasunobu Yamashita, Kazuhiro Fukatsu, Toshio Shimokawa, Masataka Koike, Tetsuo Sonomura, Manabu Kawai, Masayuki Kitano
-
The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-01-24 Shuhei Suzuki, Yoshiyuki Nagumo, Shuya Kandori, Kousuke Kojo, Satoshi Nitta, Ichiro Chihara, Masanobu Shiga, Atsushi Ikeda, Takashi Kawahara, Akio Hoshi, Hiromitsu Negoro, Mathis J. Bryan, Ayako Okuyama, Takahiro Higashi, Hiroyuki Nishiyama
-
Predictors for early recurrence beyond up-to-7 or distant metastasis after hepatocellular carcinoma resection: proposal for borderline resectable HCC Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-01-16 Norifumi Harimoto, Mariko Tsukagoshi, Takaomi Seki, Kouki Hoshino, Kei Hagiwara, Norihiro Ishii, Takamichi Igarashi, Kenichiro Araki, Koichiro Haruki, Toru Ikegami, Ken Shirabe
-
Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902) Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-01-16
Abstract Background Although there is insufficient evidence for the treatment of older patients with advanced gastric cancer, fluorouracil combined with platinum chemotherapy has been recognized as a standard first-line treatment for such populations in Japan despite the lack of efficacy and toxicity data. Methods Patients aged 75 years or older with advanced gastric cancer were enrolled. S-1 plus
-
Effects of postoperative oral elemental nutritional supplement on skeletal muscle loss after gastrectomy for gastric cancer Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-01-16 Kazuhiro Nishikawa, Yutaka Kimura, Kentaro Kishi, Kentaro Inoue, Jin Matsuyama, Yusuke Akamaru, Shigeyuki Tamura, Junji Kawada, Tomono Kawase, Ryohei Kawabata, Yoshiyuki Fujiwara, Hitoshi Kanno, Takeshi Yamada, Toshio Shimokawa, Hiroshi Imamura
-
Analgesic efficacy and safety of percutaneous thermal ablation plus cementoplasty for painful bone metastases: a systematic review and meta-analysis Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-01-13 Tomohiro Matsumoto, Rika Yoshimatsu, Marina Osaki, Junki Shibata, Hitomi Maeda, Kana Miyatake, Yoshinori Noda, Tomoaki Yamanishi, Takuji Yamagami
-
Impact of prostate position-based image-guidance in intensity-modulated radiation therapy for localized prostate cancer Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-01-08
Abstract Background/purpose The long-term clinical impact of prostate position-based image-guided radiotherapy (IGRT) for localized prostate cancer remains unclear. Materials and methods We retrospectively compared clinical outcomes following intensity-modulated radiation therapy (IMRT) with cone-beam computed tomography-based prostate position-based IGRT (P-IGRT) or without P-IGRT (non-P-IGRT). From
-
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-01-06 Kazushige Wakuda, Meiko Morita, Motoki Sekikawa, Noboru Morikawa, Keita Miura, Kosei Doshita, Yuko Iida, Hiroaki Kodama, Nobuaki Mamesaya, Haruki Kobayashi, Ryo Ko, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Koji Muramatsu, Takuya Kawata, Keita Mori, Tetsuo Shimizu, Yasuhiro Gon, Toshiaki Takahashi
-
Clinical outcomes of sentinel node navigation surgery in patients with preoperatively estimated stage IA endometrial cancer and evaluation of validity for continuing sentinel node navigation surgery based on dispersion of recurrence probability Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-01-05 Tsuyoshi Yamashita, Takahiro Itoh, Takuya Asano, Asuka Suina, Mitsutaka Nishimori, Satoru Munakata, Hideki Satoh
-
Glomerular filtration rate measurement during platinum treatment for urothelial carcinoma: optimal methods for clinical practice Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-01-05 Dag Rune Stormoen, Ulla Nordström Joensen, Gedske Daugaard, Peter Oturai, Emil Hyllested, Jakob Lauritsen, Helle Pappot
-
FOXM1 transcriptional regulation of RacGAP1 activates the PI3K/AKT signaling pathway to promote the proliferation, migration, and invasion of cervical cancer cells Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2024-01-03
Abstract Background Cervical cancer (CC) is the most common gynecological tumor disease in women, which occurs at the junction of cervical squamous columnar epithelium. We investigated the effect and mechanism of transcription factor FOXM1 synergizing RacGAP1 in the proliferation, migration, and invasion of CC cells. Methods Here, we analyzed the correlation between FOXM1 and RacGAP1 and the clinicopathological
-
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-12-31 Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Tomonori Kawasaki, Kunihiko Kobayashi, Hisao Imai, Hiroshi Kagamu
-
Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-12-29 Hideki Goto, Satoshi Ito, Masahiro Kizaki, Masaki Yamaguchi, Noriko Fukuhara, Koji Kato, Toko Saito, Yasuhito Terui, Sumiko Okubo, Tomomi Soshin, Jiewei Zeng, Hideyuki Honda, Mohamed Badawi, Jeremy A. Ross, Koji Izutsu
-
Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-12-29 Koichi Yasuda, Yusuke Uchinami, Satoshi Kano, Jun Taguchi, Daisuke Kawakita, Megumi Kitayama, Kentaro Nishioka, Takashi Mori, Fuki Koizumi, Yuri Fujii, Yasushi Shimizu, Keiji Kobashi, Seiichi Yoshimoto, Ken-ichi Nibu, Akihiro Homma, Hidefumi Aoyama
-
Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-12-28 Nobuko Nakamura, Shinji Hasebe, Shintaro Yamanaka, Tomomi Fujii, Taketsugu Fujibuchi, Teruki Kitani, Kazuto Takeuchi, Yasushi Sato, Yoshitaro Shindo, Toshifumi Ozaki, Toshihiro Nishisho, Masahiro Tabata, Yoshihiro Yakushijin
-
Clinical features and distribution of the APC variant in duodenal and ampullary polyps in patients with familial adenomatous polyposis: a multicenter retrospective cohort study in Japan Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-12-24 Yasuyuki Miyakura, Tatsuro Yamaguchi, Alan Kawarai Lefor, Sawako Tamaki, Akinari Takao, Misato Takao, Yoshiko Mori, Kenichi Chikatani, Hideyuki Ishida, Mitsuhiro Kono, Yoji Takeuchi, Hideki Ishikawa, Toshiya Nagasaki, Kazuhito Sasaki, Takaaki Matsubara, Keiji Hirata, Fumitaka Taniguchi, Kohji Tanakaya, Naohiro Tomita, Yoichi Ajioka
-
Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-12-19 Yuto Matsushita, Makito Miyake, Nobutaka Nishimura, Koshiro Nishimoto, Hideo Fukuhara, Keita Kobayashi, Masafumi Oyama, Keiji Inoue, Hideyasu Matsuyama, Kiyohide Fujimoto, Hideaki Miyake
-
Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-12-19 Zhi-jian Wei, Bai-chuan Zhou, Guo-xing Wang, Wen-xiu Han, Yong-xiang Li, A-man Xu
-
Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-12-19 Sae Ishimaru, Tatsunori Shimoi, Kuniko Sunami, Miho Nakajima, Yayoi Ando, Natsuko Okita, Kenichi Nakamura, Taro Shibata, Yasuhiro Fujiwara, Noboru Yamamoto
-
Current status and future perspective of immunotherapy for renal cell carcinoma Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-12-18 Leandro Blas, Keisuke Monji, Jun Mutaguchi, Satoshi Kobayashi, Shunsuke Goto, Takashi Matsumoto, Masaki Shiota, Junichi Inokuchi, Masatoshi Eto
In the last decade, the standard treatment for advanced renal cell carcinoma (RCC) has evolved, mainly driven by the development and approval of immune checkpoint inhibitors (ICIs). Currently, ICI monotherapy and ICI-based combinations with tyrosine kinase inhibitors and targeted therapies against mammalian target of rapamycin or vascular endothelial growth factor have become new standard treatments
-
Survival outcome of chemotherapy-naïve castration-resistant prostate cancer treated with new-generation androgen receptor axis-targeted agents in real-world analysis Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-12-16 Tatsuya Shimomura, Keiichiro Mori, Keiji Yasue, Akihiro Matsukawa, Wataru Fukuokaya, Takafumi Yanagisawa, Kenichi Hata, Masaya Murakami, Yusuke Koike, Jun Miki, Hiroki Yamada, Takahiro Kimura
-
Survival outcomes of patients with stage III colorectal cancer aged ≥ 80 years who underwent curative resection: the HiSCO-04 prospective cohort study Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-12-15 Tetsuya Mochizuki, Manabu Shimomura, Masahiro Nakahara, Tomohiro Adachi, Satoshi Ikeda, Yasufumi Saito, Yosuke Shimizu, Masatoshi Kochi, Yasuyo Ishizaki, Masanori Yoshimitsu, Yuji Takakura, Wataru Shimizu, Daisuke Sumitani, Shinya Kodama, Masahiko Fujimori, Mamoru Oheda, Hironori Kobayashi, Shintaro Akabane, Takuya Yano, Hideki Ohdan
-
Prognostic impact and survival outcomes of colon perforation in patients with metastatic colorectal cancer: a multicenter retrospective cohort study Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-12-11 Eiichi Nakao, Hidetaka Kawamura, Michitaka Honda, Yoshinao Takano, Shunji Kinuta, Takahiro Kamiga, Shigeru Yamazaki, Atsushi Muto, Satoru Shiraso, Naoyuki Yamashita, Toshiyasu Iwao, Koji Kono, Shinichi Konno
-
Pegfilgrastim for the management of neutropenia during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer patients Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-12-08 Takanori Yoshimoto, Tadayuki Oshima, Takashi Fukada, Nobuko Imamura, Takashi Nakanishi, Nobuhiko Ebisutani, Daisuke Morishita, Masatoshi Mieno, Keisuke Nakai, Hiroo Sei, Yoshitaka Kitayama, Hirotsugu Eda, Takuya Okugawa, Toshihiko Tomita, Hirokazu Fukui, Shinichiro Shinzaki
Background Neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy is a new standard for locally advanced esophageal squamous cell carcinoma. The optimal timing of pegfilgrastim with the DCF regimen to prevent febrile neutropenia (FN) remains controversial. The effectiveness of concomitant pegfilgrastim administration with continuous 5-fluorouracil (5-FU) infusion in the DCF regimen was
-
Impact of COVID-19 on gynecological cancer incidence: a large cohort study in Japan Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-12-06 Hiroaki Komatsu, Yuji Ikeda, Kei Kawana, Satoru Nagase, Kiyoshi Yoshino, Wataru Yamagami, Hideki Tokunaga, Kiyoko Kato, Tadashi Kimura, Daisuke Aoki, the Committee on Gynecologic Oncology of the Japan Society of Obstetrics, Gynecology
-
Risk factors of secondary cancer in laryngeal, oropharyngeal, or hypopharyngeal cancer after definitive therapy Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-12-07 Goshi Nishimura, Hideaki Takahashi, Daisuke Sano, Yasuhiro Arai, Takashi Hatano, Yosuke Kitani, Nobuhiko Oridate
-
Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-11-30 Yuto Terashima, Taiki Hakozaki, Yuji Uehara, Akihiko Miyanaga, Kazuo Kasahara, Masahiro Seike, Yukio Hosomi
-
Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1 Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-11-29 Yoshinori Kikuchi, Hideaki Shimada, Yutaka Hatanaka, Ichiro Kinoshita, Daiki Ikarashi, Tetsuya Nakatsura, Shigehisa Kitano, Yoichi Naito, Toshimichi Tanaka, Keishi Yamashita, Yoko Oshima, Tatsuki Nanami
-
Clinical impact of diarrhea during enteral feeding after esophagectomy Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-11-23 Ryoma Haneda, Yoshihiro Hiramatsu, Sanshiro Kawata, Wataru Soneda, Eisuke Booka, Tomohiro Murakami, Tomohiro Matsumoto, Yoshifumi Morita, Hirotoshi Kikuchi, Hiroya Takeuchi
-
Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-11-22 Shuhei Nagashima, Satoshi Kobayashi, Shotaro Tsunoda, Yui Yamachika, Yuichiro Tozuka, Taito Fukushima, Manabu Morimoto, Makoto Ueno, Junji Furuse, Shin Maeda
-
Trastuzumab deruxtecan in patients with locally advanced or metastatic HER2-positive gastric cancer: a multicenter, open-label, expanded-access study Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-11-14 Kohei Shitara, Kensei Yamaguchi, Kei Muro, Hisateru Yasui, Daisuke Sakai, Takashi Oshima, Masahiro Fujimura, Yuta Sato, Shunsuke Yamazaki, Tatsuya Wakabayashi, Masahiro Sugihara, Takahiro Kamio, Hirokazu Shoji
-
Patient vulnerability is associated with poor prognosis following upfront hepatectomy for colorectal liver metastasis Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-11-09 Kosuke Mima, Hiromitsu Hayashi, Yuki Adachi, Takuya Tajiri, Takashi Ofuchi, Kosuke Kanemitsu, Daisuke Ogawa, Shinsei Yumoto, Takashi Matsumoto, Rumi Itoyama, Yuki Kitano, Shigeki Nakagawa, Hirohisa Okabe, Hideo Baba
-
Oral frailty is a risk factor for body weight loss after gastrectomy: a single-center, retrospective study Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-10-25 Ryugo Teranishi, Kazuyoshi Yamamoto, Yukinori Kurokawa, Toshihiro Uchihashi, Akinari Sugauchi, Chihiro Tanikawa, Kosuke Kubo, Tsuyoshi Takahashi, Takuro Saito, Kota Momose, Kotaro Yamashita, Koji Tanaka, Tomoki Makino, Kiyokazu Nakajima, Emiko Tanaka Isomura, Hidetoshi Eguchi, Yuichiro Doki
-
Current trends in the promising immune checkpoint inhibition and radiotherapy combination for locally advanced and metastatic urothelial carcinoma Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-10-24 Takeshi Sano, Ryoichi Saito, Rihito Aizawa, Tsubasa Watanabe, Kaoru Murakami, Yuki Kita, Kimihiko Masui, Takayuki Goto, Takashi Mizowaki, Takashi Kobayashi
-
Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort study Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-10-21 Hirokazu Kagawa, Fumihiko Urabe, Yuria Kiuchi, Kota Katsumi, Ryotaro Yamaguchi, Yushi Suhara, Kentaro Yoshihara, Yuma Goto, Ibuki Sadakane, Yuji Yata, Shun Saito, Shiro Kurawaki, Shino Ajisaka, Keiichiro Miyajima, Kazuhiro Takahashi, Kosuke Iwatani, Yu Imai, Keigo Sakanaka, Minoru Nakazono, Takashi Kurauchi, Sotaro Kayano, Hajime Onuma, Koichi Aikawa, Takafumi Yanagisawa, Kojiro Tashiro, Shunsuke Tsuzuki
-
Comparison of perioperative outcomes and complications between intracorporeal, extracorporeal, and hybrid ileal conduit urinary diversion during robot-assisted radical cystectomy: a comparative propensity score-matched analysis from nationwide multi-institutional study in Japan Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-10-21 Shuichi Morizane, Keita Nakane, Toshiaki Tanaka, Kenji Zennami, Kentaro Muraoka, Shin Ebara, Noriyoshi Miura, Koichi Uemura, Ryuta Sobu, Akio Hoshi, Rikiya Taoka, Mikio Sugimoto, Hisashi Noma, Hiroshi Sunada, Hiroyuki Nishiyama, Tomonori Habuchi, Ichiro Ikeda, Takashi Saika, Kazuhide Makiyama, Ryoichi Shiroki, Naoya Masumori, Takuya Koie, Atsushi Takenaka
Background To investigate the impact of different urinary diversion (UD) techniques on the peri- and postoperative complications of robot-assisted radical cystectomy (RARC) with ileal conduit. Methods We retrospectively analyzed 373 patients undergoing RARC with ileal conduit at 11 institutions in Japan between April 2018 and December 2021. Propensity score weighting was performed to adjust for confounding
-
Usefulness of genotyping APC gene for individualizing management of patients with familial adenomatous polyposis Int. J. Clin. Oncol. (IF 3.3) Pub Date : 2023-10-18 Yoshiko Mori, Hideyuki Ishida, Noriyasu Chika, Tetsuya Ito, Kunihiko Amano, Kenichi Chikatani, Yoji Takeuchi, Mitsuhiro Kono, Satoki Shichijo, Akiko Chino, Toshiya Nagasaki, Akinari Takao, Misato Takao, Sakiko Nakamori, Kazuhito Sasaki, Kiwamu Akagi, Tatsuro Yamaguchi, Kohji Tanakaya, Tomita Naohiro, Yoichi Ajioka